Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘NASDAQ:KALV’

James Flynn Deerfield Management

Hedge Funds Are Crazy About KalVista Pharmaceuticals, Inc. (KALV)

Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief......(read more)

13D Filing: RA Capital Management and Kalvista Pharmaceuticals Inc. (KALV)

Kalvista Pharmaceuticals Inc. (NASDAQ:KALV): Peter Kolchinsky’s RA Capital Management filed an amended 13D. You can check out RA Capital Management......(read more)
10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

13D Filing: Longwood Fund II, L.P. and Kalvista Pharmaceuticals Inc. (KALV)

You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)